Search results for: Real World Evidence (RWE)
Filter search results
Can we “Netflix” the Broken Antibiotics Market?
28 September 2022, 3:00pm
…years, Jason has shaped health economics and market access strategies and evidence for the world’s leading pharmaceutical and biotechnology companies. Following careers in academia, consultancy, industry and government, Jason has…
Closing the ‘Know-Do’ Gap for Health Systems Reform at the Policy Level
1 April 2020
The World Health Organisation (WHO) has become quite skilled at promoting what changes are desirable in health care systems, and why, but has largely left how to implement those changes…
A Prescription for Green Healthcare Delivery: Insights from an Expert Sustainability Webinar
19 July 2023
…international collaboration between NICE and peer HTA bodies like CADTH The development of a world-leading set of standards through the British Standards Institute Partnership and collaboration between the key stakeholders…
OHE Annual Lecture 2023 | The ECO-nomics of Health in a Shifting Climate: Fostering Well-being, Sustainable Livelihoods, and a Greener Future
13 September 2023, 6:00pm
…and inform health policymakers, the Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world and to raise awareness of research and evidence…
OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade
7 November 2016, 12:00am
…the IOM termed The Learning Healthcare System with the use of Big Data and an emphasis on gathering «real world evidence» by tracking NHS patients through observational studies and more…
Does Relative Effectiveness Vary Across Europe?
9 August 2011
…found that examine differences in effectiveness across countries – i.e., how well a treatment performs in the real world. The authors suggest that collecting and analysing reliable and comparable registry…
Groundbreaking EQ-5D Project Launched in the United Arab Emirates
5 November 2013
…the United Arab Emirates”. It is funded by Eli Lilly & Company (Global Patient Outcomes & Real World Evidence) and the EuroQol Group. Ethics consent for the research has been…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
28 October 2015
…allow separate and distinct prices to be paid for major patient subgroups and indications, based upon the value demonstrated in clinical trials and real-world settings, may be preferred by stakeholders,…
Invitation to OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade – 7 November 2016
19 October 2016
…with the use of Big Data and an emphasis on gathering «real world evidence» by tracking NHS patients through observational studies and more pragmatic trials; Meeting the challenge of demonstrating…